# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-108834
Filing Date
2025-08-14
Accepted
2025-08-14 16:02:32
Documents
58
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | eq-20250630.htm iXBRL | 10-Q | 2322120
2 | EX-4.5 | eq-ex4_5.htm | EX-4.5 | 246881
3 | EX-31.1 | eq-ex31_1.htm | EX-31.1 | 12671
4 | EX-32.1 | eq-ex32_1.htm | EX-32.1 | 8884
| Complete submission text file | 0000950170-25-108834.txt |  | 8389188

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eq-20250630.xsd | EX-101.SCH | 1119619
61 | EXTRACTED XBRL INSTANCE DOCUMENT | eq-20250630_htm.xml | XML | 1267906

Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 251218533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)